nodes	percent_of_prediction	percent_of_DWPC	metapath
Ethylmorphine—CYP2D6—Parkinson's disease	0.889	1	CbGaD
Ethylmorphine—OPRM1—telencephalic ventricle—Parkinson's disease	0.0047	0.192	CbGeAlD
Ethylmorphine—OPRM1—nerve—Parkinson's disease	0.00296	0.121	CbGeAlD
Ethylmorphine—Galantamine—CHRNA4—Parkinson's disease	0.00248	0.243	CrCbGaD
Ethylmorphine—Dihydrocodeine—CYP2D6—Parkinson's disease	0.00146	0.143	CrCbGaD
Ethylmorphine—OPRM1—brainstem—Parkinson's disease	0.00127	0.052	CbGeAlD
Ethylmorphine—OPRM1—forebrain—Parkinson's disease	0.00123	0.0502	CbGeAlD
Ethylmorphine—Hydrocodone—CYP2D6—Parkinson's disease	0.00112	0.109	CrCbGaD
Ethylmorphine—POR—medulla oblongata—Parkinson's disease	0.00112	0.0456	CbGeAlD
Ethylmorphine—POR—midbrain—Parkinson's disease	0.00102	0.0417	CbGeAlD
Ethylmorphine—Oxycodone—CYP2D6—Parkinson's disease	0.00102	0.0999	CrCbGaD
Ethylmorphine—POR—spinal cord—Parkinson's disease	0.000995	0.0407	CbGeAlD
Ethylmorphine—Codeine—CYP2D6—Parkinson's disease	0.000971	0.0953	CrCbGaD
Ethylmorphine—Hydromorphone—CYP2D6—Parkinson's disease	0.000924	0.0907	CrCbGaD
Ethylmorphine—CYP2D6—hindbrain—Parkinson's disease	0.000889	0.0364	CbGeAlD
Ethylmorphine—Galantamine—CYP2D6—Parkinson's disease	0.000882	0.0865	CrCbGaD
Ethylmorphine—OPRM1—midbrain—Parkinson's disease	0.00081	0.0331	CbGeAlD
Ethylmorphine—OPRM1—spinal cord—Parkinson's disease	0.00079	0.0323	CbGeAlD
Ethylmorphine—POR—cerebellum—Parkinson's disease	0.000789	0.0323	CbGeAlD
Ethylmorphine—Morphine—CYP2D6—Parkinson's disease	0.000786	0.0771	CrCbGaD
Ethylmorphine—OPRM1—head—Parkinson's disease	0.000702	0.0287	CbGeAlD
Ethylmorphine—OPRM1—nervous system—Parkinson's disease	0.000666	0.0272	CbGeAlD
Ethylmorphine—OPRM1—central nervous system—Parkinson's disease	0.000641	0.0262	CbGeAlD
Ethylmorphine—POR—brain—Parkinson's disease	0.000641	0.0262	CbGeAlD
Ethylmorphine—Morphine—ABCB1—Parkinson's disease	0.000561	0.0551	CrCbGaD
Ethylmorphine—CYP2B6—cardiovascular system—Parkinson's disease	0.00056	0.0229	CbGeAlD
Ethylmorphine—CYP2D6—brainstem—Parkinson's disease	0.000509	0.0208	CbGeAlD
Ethylmorphine—OPRM1—brain—Parkinson's disease	0.000509	0.0208	CbGeAlD
Ethylmorphine—CYP2D6—forebrain—Parkinson's disease	0.000492	0.0201	CbGeAlD
Ethylmorphine—CYP2B6—head—Parkinson's disease	0.000379	0.0155	CbGeAlD
Ethylmorphine—CYP2B6—nervous system—Parkinson's disease	0.000359	0.0147	CbGeAlD
Ethylmorphine—CYP2B6—central nervous system—Parkinson's disease	0.000346	0.0142	CbGeAlD
Ethylmorphine—CYP2D6—head—Parkinson's disease	0.000282	0.0115	CbGeAlD
Ethylmorphine—CYP2B6—brain—Parkinson's disease	0.000275	0.0112	CbGeAlD
Ethylmorphine—CYP3A4—nervous system—Parkinson's disease	0.000271	0.0111	CbGeAlD
Ethylmorphine—CYP2D6—nervous system—Parkinson's disease	0.000267	0.0109	CbGeAlD
Ethylmorphine—CYP3A4—central nervous system—Parkinson's disease	0.000261	0.0107	CbGeAlD
Ethylmorphine—CYP2D6—central nervous system—Parkinson's disease	0.000257	0.0105	CbGeAlD
Ethylmorphine—CYP2D6—cerebellum—Parkinson's disease	0.000251	0.0103	CbGeAlD
Ethylmorphine—CYP2D6—brain—Parkinson's disease	0.000204	0.00835	CbGeAlD
Ethylmorphine—CYP3A7—Metapathway biotransformation—COMT—Parkinson's disease	0.000184	0.00241	CbGpPWpGaD
Ethylmorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR1A—Parkinson's disease	0.000184	0.0024	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000183	0.0024	CbGpPWpGaD
Ethylmorphine—CYP2B6—Biological oxidations—CYP2D6—Parkinson's disease	0.000182	0.00238	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCRs, Class A Rhodopsin-like—DRD2—Parkinson's disease	0.000181	0.00237	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCRs, Class A Rhodopsin-like—HTR7—Parkinson's disease	0.000181	0.00237	CbGpPWpGaD
Ethylmorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—TAC1—Parkinson's disease	0.000181	0.00237	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metapathway biotransformation—CYP2D6—Parkinson's disease	0.00018	0.00235	CbGpPWpGaD
Ethylmorphine—CYP2D6—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000179	0.00235	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling by GPCR—GPR37—Parkinson's disease	0.000177	0.00232	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling by GPCR—DGKQ—Parkinson's disease	0.000177	0.00232	CbGpPWpGaD
Ethylmorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD1—Parkinson's disease	0.000177	0.00232	CbGpPWpGaD
Ethylmorphine—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP2E1—Parkinson's disease	0.000176	0.0023	CbGpPWpGaD
Ethylmorphine—OPRM1—TCR Signaling Pathway—IL1B—Parkinson's disease	0.000175	0.00229	CbGpPWpGaD
Ethylmorphine—CYP3A4—Oxidation by Cytochrome P450—CYP2E1—Parkinson's disease	0.000173	0.00227	CbGpPWpGaD
Ethylmorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD3—Parkinson's disease	0.000172	0.00225	CbGpPWpGaD
Ethylmorphine—CYP3A7—Biological oxidations—GSTM1—Parkinson's disease	0.000171	0.00223	CbGpPWpGaD
Ethylmorphine—CYP2D6—Biological oxidations—MAOB—Parkinson's disease	0.00017	0.00223	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000168	0.0022	CbGpPWpGaD
Ethylmorphine—CYP2B6—Biological oxidations—CYP2E1—Parkinson's disease	0.000167	0.00218	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000164	0.00215	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling by GPCR—PPP1R1B—Parkinson's disease	0.000162	0.00212	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCR ligand binding—ADORA2A—Parkinson's disease	0.000161	0.00211	CbGpPWpGaD
Ethylmorphine—OPRM1—TCR Signaling Pathway—MAPK8—Parkinson's disease	0.00016	0.0021	CbGpPWpGaD
Ethylmorphine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2D6—Parkinson's disease	0.000156	0.00204	CbGpPWpGaD
Ethylmorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR7—Parkinson's disease	0.000155	0.00203	CbGpPWpGaD
Ethylmorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—DRD2—Parkinson's disease	0.000155	0.00203	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCR downstream signaling—GRK5—Parkinson's disease	0.000148	0.00194	CbGpPWpGaD
Ethylmorphine—CYP3A4—Phase 1 - Functionalization of compounds—CYP2E1—Parkinson's disease	0.000142	0.00186	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCR ligand binding—HTR1A—Parkinson's disease	0.00014	0.00183	CbGpPWpGaD
Ethylmorphine—CYP2B6—Biological oxidations—COMT—Parkinson's disease	0.000138	0.0018	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCR ligand binding—TAC1—Parkinson's disease	0.000138	0.0018	CbGpPWpGaD
Ethylmorphine—CYP2B6—Biological oxidations—GSTP1—Parkinson's disease	0.000137	0.0018	CbGpPWpGaD
Ethylmorphine—CYP2B6—Biological oxidations—MAOA—Parkinson's disease	0.000137	0.00179	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metapathway biotransformation—COMT—Parkinson's disease	0.000136	0.00178	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metapathway biotransformation—GSTP1—Parkinson's disease	0.000135	0.00177	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCR ligand binding—DRD1—Parkinson's disease	0.000135	0.00177	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling by GPCR—GRK5—Parkinson's disease	0.000135	0.00176	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCR downstream signaling—GRM4—Parkinson's disease	0.000133	0.00174	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCR ligand binding—DRD3—Parkinson's disease	0.000131	0.00171	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCRs, Class A Rhodopsin-like—HTR2A—Parkinson's disease	0.000127	0.00166	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—VPS35—Parkinson's disease	0.000127	0.00166	CbGpPWpGaD
Ethylmorphine—CYP2B6—Biological oxidations—GSTM1—Parkinson's disease	0.000126	0.00165	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCR downstream signaling—PENK—Parkinson's disease	0.000126	0.00165	CbGpPWpGaD
Ethylmorphine—CYP3A4—Biological oxidations—GSTA4—Parkinson's disease	0.000125	0.00163	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metapathway biotransformation—GSTM1—Parkinson's disease	0.000124	0.00163	CbGpPWpGaD
Ethylmorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—EDN1—Parkinson's disease	0.000124	0.00163	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metapathway biotransformation—GSTA4—Parkinson's disease	0.000123	0.00161	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—ND3—Parkinson's disease	0.000121	0.00158	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—MCCC1—Parkinson's disease	0.000121	0.00158	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling by GPCR—GRM4—Parkinson's disease	0.000121	0.00158	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCR ligand binding—HTR7—Parkinson's disease	0.000118	0.00155	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCR ligand binding—DRD2—Parkinson's disease	0.000118	0.00155	CbGpPWpGaD
Ethylmorphine—CYP3A4—Phase 1 - Functionalization of compounds—MAOA—Parkinson's disease	0.000117	0.00153	CbGpPWpGaD
Ethylmorphine—CYP2D6—Biological oxidations—CYP2E1—Parkinson's disease	0.000116	0.00151	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCR downstream signaling—PDYN—Parkinson's disease	0.000115	0.00151	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling by GPCR—PENK—Parkinson's disease	0.000114	0.0015	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metapathway biotransformation—CYP2E1—Parkinson's disease	0.000114	0.00149	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—OMD—Parkinson's disease	0.000114	0.00149	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—TALDO1—Parkinson's disease	0.000114	0.00149	CbGpPWpGaD
Ethylmorphine—CYP3A4—Biological oxidations—MAOB—Parkinson's disease	0.000111	0.00146	CbGpPWpGaD
Ethylmorphine—OPRM1—Class A/1 (Rhodopsin-like receptors)—HTR2A—Parkinson's disease	0.000109	0.00142	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—NDUFB11—Parkinson's disease	0.000108	0.00141	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCR downstream signaling—GRM5—Parkinson's disease	0.000107	0.0014	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—GPR37—Parkinson's disease	0.000105	0.00137	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—DGKQ—Parkinson's disease	0.000105	0.00137	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling by GPCR—PDYN—Parkinson's disease	0.000105	0.00137	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—GCH1—Parkinson's disease	0.000103	0.00135	CbGpPWpGaD
Ethylmorphine—OPRM1—TCR Signaling Pathway—IL6—Parkinson's disease	0.000102	0.00134	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling by GPCR—GRM5—Parkinson's disease	9.73e-05	0.00127	CbGpPWpGaD
Ethylmorphine—CYP2D6—Biological oxidations—COMT—Parkinson's disease	9.59e-05	0.00125	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—PPP1R1B—Parkinson's disease	9.59e-05	0.00125	CbGpPWpGaD
Ethylmorphine—CYP2D6—Biological oxidations—GSTP1—Parkinson's disease	9.55e-05	0.00125	CbGpPWpGaD
Ethylmorphine—CYP2D6—Biological oxidations—MAOA—Parkinson's disease	9.52e-05	0.00125	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCR ligand binding—EDN1—Parkinson's disease	9.47e-05	0.00124	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metapathway biotransformation—COMT—Parkinson's disease	9.46e-05	0.00124	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metapathway biotransformation—GSTP1—Parkinson's disease	9.41e-05	0.00123	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—GBA—Parkinson's disease	9.17e-05	0.0012	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—FBP1—Parkinson's disease	9.17e-05	0.0012	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—DBH—Parkinson's disease	9.17e-05	0.0012	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCR downstream signaling—ADORA2A—Parkinson's disease	9.11e-05	0.00119	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—MCCC1—Parkinson's disease	8.95e-05	0.00117	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—ND3—Parkinson's disease	8.95e-05	0.00117	CbGpPWpGaD
Ethylmorphine—CYP2D6—Biological oxidations—GSTM1—Parkinson's disease	8.77e-05	0.00115	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metapathway biotransformation—GSTM1—Parkinson's disease	8.65e-05	0.00113	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—TALDO1—Parkinson's disease	8.41e-05	0.0011	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—OMD—Parkinson's disease	8.41e-05	0.0011	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—RIT2—Parkinson's disease	8.38e-05	0.0011	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCR ligand binding—HTR2A—Parkinson's disease	8.28e-05	0.00108	CbGpPWpGaD
Ethylmorphine—CYP3A4—Biological oxidations—CYP2D6—Parkinson's disease	8.27e-05	0.00108	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling by GPCR—ADORA2A—Parkinson's disease	8.27e-05	0.00108	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metapathway biotransformation—CYP2D6—Parkinson's disease	8.16e-05	0.00107	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—NDUFB11—Parkinson's disease	7.98e-05	0.00104	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—GRK5—Parkinson's disease	7.95e-05	0.00104	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCR downstream signaling—HTR1A—Parkinson's disease	7.9e-05	0.00103	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCR downstream signaling—TAC1—Parkinson's disease	7.78e-05	0.00102	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCR downstream signaling—DRD1—Parkinson's disease	7.63e-05	0.000998	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—GCH1—Parkinson's disease	7.61e-05	0.000995	CbGpPWpGaD
Ethylmorphine—CYP3A4—Biological oxidations—CYP2E1—Parkinson's disease	7.57e-05	0.00099	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metapathway biotransformation—CYP2E1—Parkinson's disease	7.46e-05	0.000976	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCR downstream signaling—DRD3—Parkinson's disease	7.39e-05	0.000967	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling by GPCR—HTR1A—Parkinson's disease	7.18e-05	0.000939	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—GRM4—Parkinson's disease	7.13e-05	0.000932	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling by GPCR—TAC1—Parkinson's disease	7.07e-05	0.000924	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling by GPCR—DRD1—Parkinson's disease	6.93e-05	0.000906	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCR downstream signaling—ADRBK1—Parkinson's disease	6.9e-05	0.000903	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—GBA—Parkinson's disease	6.78e-05	0.000887	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—FBP1—Parkinson's disease	6.78e-05	0.000887	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—DBH—Parkinson's disease	6.78e-05	0.000887	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—PENK—Parkinson's disease	6.76e-05	0.000884	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—MAG—Parkinson's disease	6.76e-05	0.000884	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—DDC—Parkinson's disease	6.73e-05	0.00088	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling by GPCR—DRD3—Parkinson's disease	6.71e-05	0.000878	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCR downstream signaling—HTR7—Parkinson's disease	6.68e-05	0.000874	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCR downstream signaling—DRD2—Parkinson's disease	6.68e-05	0.000874	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—GSTA4—Parkinson's disease	6.36e-05	0.000831	CbGpPWpGaD
Ethylmorphine—CYP3A4—Biological oxidations—COMT—Parkinson's disease	6.27e-05	0.00082	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling by GPCR—ADRBK1—Parkinson's disease	6.27e-05	0.00082	CbGpPWpGaD
Ethylmorphine—CYP3A4—Biological oxidations—GSTP1—Parkinson's disease	6.24e-05	0.000816	CbGpPWpGaD
Ethylmorphine—CYP3A4—Biological oxidations—MAOA—Parkinson's disease	6.23e-05	0.000814	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—MCCC1—Parkinson's disease	6.22e-05	0.000814	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—ND3—Parkinson's disease	6.22e-05	0.000814	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metapathway biotransformation—COMT—Parkinson's disease	6.18e-05	0.000809	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—PDYN—Parkinson's disease	6.18e-05	0.000808	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metapathway biotransformation—GSTP1—Parkinson's disease	6.16e-05	0.000805	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling by GPCR—DRD2—Parkinson's disease	6.07e-05	0.000794	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling by GPCR—HTR7—Parkinson's disease	6.07e-05	0.000794	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—TALDO1—Parkinson's disease	5.85e-05	0.000765	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—OMD—Parkinson's disease	5.85e-05	0.000765	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—GFAP—Parkinson's disease	5.81e-05	0.00076	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—GRM5—Parkinson's disease	5.75e-05	0.000751	CbGpPWpGaD
Ethylmorphine—CYP3A4—Biological oxidations—GSTM1—Parkinson's disease	5.74e-05	0.00075	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—PLA2G6—Parkinson's disease	5.72e-05	0.000749	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—MAOB—Parkinson's disease	5.67e-05	0.000741	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metapathway biotransformation—GSTM1—Parkinson's disease	5.66e-05	0.00074	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—NDUFB11—Parkinson's disease	5.54e-05	0.000725	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCR downstream signaling—EDN1—Parkinson's disease	5.35e-05	0.0007	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—GCH1—Parkinson's disease	5.29e-05	0.000692	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—FGF20—Parkinson's disease	5.04e-05	0.000659	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—DDC—Parkinson's disease	4.98e-05	0.000651	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—ADORA2A—Parkinson's disease	4.88e-05	0.000639	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling by GPCR—EDN1—Parkinson's disease	4.86e-05	0.000636	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—GBA—Parkinson's disease	4.71e-05	0.000617	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—DBH—Parkinson's disease	4.71e-05	0.000617	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—FBP1—Parkinson's disease	4.71e-05	0.000617	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—GSTA4—Parkinson's disease	4.7e-05	0.000615	CbGpPWpGaD
Ethylmorphine—OPRM1—GPCR downstream signaling—HTR2A—Parkinson's disease	4.68e-05	0.000612	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—INSR—Parkinson's disease	4.51e-05	0.00059	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—FGB—Parkinson's disease	4.26e-05	0.000557	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling by GPCR—HTR2A—Parkinson's disease	4.25e-05	0.000556	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—HTR1A—Parkinson's disease	4.24e-05	0.000554	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—PLA2G6—Parkinson's disease	4.23e-05	0.000554	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—CYP2D6—Parkinson's disease	4.21e-05	0.000551	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—MAOB—Parkinson's disease	4.19e-05	0.000548	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—TAC1—Parkinson's disease	4.17e-05	0.000546	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—CTGF—Parkinson's disease	4.13e-05	0.000541	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—DRD1—Parkinson's disease	4.09e-05	0.000535	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—ND3—Parkinson's disease	4.07e-05	0.000532	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—MCCC1—Parkinson's disease	4.07e-05	0.000532	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—DRD3—Parkinson's disease	3.96e-05	0.000519	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—CYP2E1—Parkinson's disease	3.85e-05	0.000504	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—TALDO1—Parkinson's disease	3.82e-05	0.0005	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—OMD—Parkinson's disease	3.82e-05	0.0005	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—NQO1—Parkinson's disease	3.81e-05	0.000498	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—TH—Parkinson's disease	3.75e-05	0.000491	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—ADRBK1—Parkinson's disease	3.7e-05	0.000484	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—NDUFB11—Parkinson's disease	3.62e-05	0.000474	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—CYCS—Parkinson's disease	3.6e-05	0.000471	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—HTR7—Parkinson's disease	3.59e-05	0.000469	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—DRD2—Parkinson's disease	3.59e-05	0.000469	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—DDC—Parkinson's disease	3.46e-05	0.000453	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—GCH1—Parkinson's disease	3.46e-05	0.000452	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—GSTA4—Parkinson's disease	3.27e-05	0.000427	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—COMT—Parkinson's disease	3.19e-05	0.000417	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—GSTP1—Parkinson's disease	3.18e-05	0.000415	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—MAOA—Parkinson's disease	3.17e-05	0.000414	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—HMOX1—Parkinson's disease	3.13e-05	0.00041	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—CYP2D6—Parkinson's disease	3.11e-05	0.000407	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—GBA—Parkinson's disease	3.08e-05	0.000403	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—DBH—Parkinson's disease	3.08e-05	0.000403	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—FBP1—Parkinson's disease	3.08e-05	0.000403	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—CTGF—Parkinson's disease	3.06e-05	0.0004	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—ABCB1—Parkinson's disease	3.01e-05	0.000393	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—IGF2—Parkinson's disease	3e-05	0.000393	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—PLA2G6—Parkinson's disease	2.94e-05	0.000385	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—GSTM1—Parkinson's disease	2.92e-05	0.000382	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—MAOB—Parkinson's disease	2.91e-05	0.000381	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—IGF1R—Parkinson's disease	2.91e-05	0.00038	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—EDN1—Parkinson's disease	2.87e-05	0.000375	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—CYP2E1—Parkinson's disease	2.85e-05	0.000373	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—NQO1—Parkinson's disease	2.82e-05	0.000368	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—GPX1—Parkinson's disease	2.79e-05	0.000366	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—TH—Parkinson's disease	2.78e-05	0.000363	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—CYCS—Parkinson's disease	2.66e-05	0.000349	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—NGF—Parkinson's disease	2.64e-05	0.000345	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—MTHFR—Parkinson's disease	2.58e-05	0.000337	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—HTR2A—Parkinson's disease	2.51e-05	0.000328	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—APOE—Parkinson's disease	2.4e-05	0.000314	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—COMT—Parkinson's disease	2.36e-05	0.000309	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—GSTP1—Parkinson's disease	2.35e-05	0.000307	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—MAOA—Parkinson's disease	2.34e-05	0.000306	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—APOE—Parkinson's disease	2.33e-05	0.000305	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—HMOX1—Parkinson's disease	2.32e-05	0.000303	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—DDC—Parkinson's disease	2.26e-05	0.000296	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—ABCB1—Parkinson's disease	2.22e-05	0.000291	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—GSTM1—Parkinson's disease	2.16e-05	0.000282	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—GSTA4—Parkinson's disease	2.14e-05	0.000279	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—CTGF—Parkinson's disease	2.12e-05	0.000278	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—GPX1—Parkinson's disease	2.07e-05	0.00027	CbGpPWpGaD
Ethylmorphine—CYP3A7—Metabolism—INS—Parkinson's disease	2.05e-05	0.000268	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—INS—Parkinson's disease	1.99e-05	0.000261	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—CYP2E1—Parkinson's disease	1.98e-05	0.000259	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—NQO1—Parkinson's disease	1.96e-05	0.000256	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—TH—Parkinson's disease	1.93e-05	0.000252	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—PLA2G6—Parkinson's disease	1.92e-05	0.000252	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—MTHFR—Parkinson's disease	1.91e-05	0.00025	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—MAOB—Parkinson's disease	1.9e-05	0.000249	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—CYCS—Parkinson's disease	1.85e-05	0.000242	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—APOE—Parkinson's disease	1.78e-05	0.000232	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—COMT—Parkinson's disease	1.64e-05	0.000215	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—GSTP1—Parkinson's disease	1.63e-05	0.000214	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—MAOA—Parkinson's disease	1.63e-05	0.000213	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—HMOX1—Parkinson's disease	1.61e-05	0.000211	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—ABCB1—Parkinson's disease	1.55e-05	0.000202	CbGpPWpGaD
Ethylmorphine—CYP2B6—Metabolism—INS—Parkinson's disease	1.52e-05	0.000198	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—GSTM1—Parkinson's disease	1.5e-05	0.000196	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—CASP3—Parkinson's disease	1.48e-05	0.000194	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling by GPCR—IL6—Parkinson's disease	1.48e-05	0.000193	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—GPX1—Parkinson's disease	1.44e-05	0.000188	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—CYP2D6—Parkinson's disease	1.41e-05	0.000185	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—CTGF—Parkinson's disease	1.39e-05	0.000182	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—MAPK8—Parkinson's disease	1.36e-05	0.000179	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—MTHFR—Parkinson's disease	1.33e-05	0.000173	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—CYP2E1—Parkinson's disease	1.29e-05	0.000169	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—NQO1—Parkinson's disease	1.28e-05	0.000167	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—TH—Parkinson's disease	1.26e-05	0.000165	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—APOE—Parkinson's disease	1.23e-05	0.000161	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—CYCS—Parkinson's disease	1.21e-05	0.000158	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—COMT—Parkinson's disease	1.07e-05	0.00014	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—GSTP1—Parkinson's disease	1.07e-05	0.00014	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—MAOA—Parkinson's disease	1.06e-05	0.000139	CbGpPWpGaD
Ethylmorphine—CYP2D6—Metabolism—INS—Parkinson's disease	1.05e-05	0.000138	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—HMOX1—Parkinson's disease	1.05e-05	0.000138	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—ABCB1—Parkinson's disease	1.01e-05	0.000132	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—GSTM1—Parkinson's disease	9.81e-06	0.000128	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—GPX1—Parkinson's disease	9.39e-06	0.000123	CbGpPWpGaD
Ethylmorphine—OPRM1—Signaling Pathways—IL6—Parkinson's disease	8.71e-06	0.000114	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—MTHFR—Parkinson's disease	8.67e-06	0.000113	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—APOE—Parkinson's disease	8.07e-06	0.000106	CbGpPWpGaD
Ethylmorphine—CYP3A4—Metabolism—INS—Parkinson's disease	6.89e-06	9.02e-05	CbGpPWpGaD
